Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action

Author： Lalive Patrice H.   Neuhaus Oliver  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.5, 2011-05, pp. : 401-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glatiramer acetate for the treatment of multiple sclerosis

By Wolinsky Jerry S  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 875-891

Informa Healthcare

Access to resources Recommend Favorite

Glatiramer acetate in the treatment of multiple sclerosis

By Sela Michael   Teitelbaum Dvora  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1149-1165

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment

By Messina Silvia   Patti Francesco  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1349-1359

Informa Healthcare

Access to resources Recommend Favorite

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis

By Simpson D.   Noble S.   Perry C.  

CNS Drugs, Vol. 16, Iss. 12, 2002-01 ,pp. : 825-850

Adis International

Access to resources Recommend Favorite

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis

By Carter Natalie J.   Keating Gillian M.  

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1545-1577

Adis International

Access to resources Recommend Favorite